Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)

Albert Fournier; Roxana Oprisiu; Jean Michel Achard; Olaf H. Klungel; Hubert G.M. Leufkens; Anthonius De Boer; W. T. Longstreth; Robert C. Kaplan; Nicholas L. Smith; Bruce M. Psaty

doi:10.1001/archinte.161.17.2152

Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)

Albert Fournier, Roxana Oprisiu, Jean Michel Achard, Olaf H. Klungel, Hubert G.M. Leufkens, Anthonius De Boer, W. T. Longstreth, Robert C. Kaplan, Nicholas L. Smith, Bruce M. Psaty

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2152-2153
Number of pages	2
Journal	Archives of internal medicine
Volume	161
Issue number	17
DOIs	https://doi.org/10.1001/archinte.161.17.2152
State	Published - Sep 24 2001
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1001/archinte.161.17.2152

Cite this

Fournier, A., Oprisiu, R., Michel Achard, J., Klungel, O. H., Leufkens, H. G. M., De Boer, A., Longstreth, W. T., Kaplan, R. C., Smith, N. L., & Psaty, B. M. (2001). Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters). Archives of internal medicine, 161(17), 2152-2153. https://doi.org/10.1001/archinte.161.17.2152

Fournier, A, Oprisiu, R, Michel Achard, J, Klungel, OH, Leufkens, HGM, De Boer, A, Longstreth, WT, Kaplan, RC, Smith, NL & Psaty, BM 2001, 'Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)', Archives of internal medicine, vol. 161, no. 17, pp. 2152-2153. https://doi.org/10.1001/archinte.161.17.2152

@article{aee8e363a0194d4b8c7e4ee1862fd20f,

title = "Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)",

author = "Albert Fournier and Roxana Oprisiu and {Michel Achard}, Jean and Klungel, {Olaf H.} and Leufkens, {Hubert G.M.} and {De Boer}, Anthonius and Longstreth, {W. T.} and Kaplan, {Robert C.} and Smith, {Nicholas L.} and Psaty, {Bruce M.}",

year = "2001",

month = sep,

day = "24",

doi = "10.1001/archinte.161.17.2152",

language = "English (US)",

volume = "161",

pages = "2152--2153",

journal = "Archives of internal medicine",

issn = "0003-9926",

publisher = "American Medical Association",

number = "17",

}

TY - JOUR

T1 - Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)

AU - Fournier, Albert

AU - Oprisiu, Roxana

AU - Michel Achard, Jean

AU - Klungel, Olaf H.

AU - Leufkens, Hubert G.M.

AU - De Boer, Anthonius

AU - Longstreth, W. T.

AU - Kaplan, Robert C.

AU - Smith, Nicholas L.

AU - Psaty, Bruce M.

PY - 2001/9/24

Y1 - 2001/9/24

UR - http://www.scopus.com/inward/record.url?scp=0035944363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035944363&partnerID=8YFLogxK

U2 - 10.1001/archinte.161.17.2152

DO - 10.1001/archinte.161.17.2152

M3 - Letter

C2 - 11570952

AN - SCOPUS:0035944363

SN - 0003-9926

VL - 161

SP - 2152

EP - 2153

JO - Archives of internal medicine

JF - Archives of internal medicine

IS - 17

ER -

Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this